|
|
|
Diphenylpyraline Hydrochloride |
is a Star Product of
|
|
Shanghai Eliv Pharmaceutical Co., Ltd. |
|
|
General information |
Registration name: Diphenylpyraline Hydrochloride |
Other product names:
4-Diphenylmethoxy-1-methylpiperidine hydrochloride
|
CAS number 132-18-3 |
|
EINECS: 205-049-3 |
Formula: C19H23NO HCl |
|
|
Detailed information on the Star Product |
Content(%) | 98.0-101.0%
|
Related substances | The sum of the areas of any secondary peaks in not greater than the area of the peak due to the internal standard
|
The result is conform to the BP |
|
|
|
Information on the supplier
Shanghai Eliv Pharmaceutical Co., Ltd. |
Shanghai eliv pharmaceutical Co.,Ltd. was founded in 2011. Eliv focus on R&D and production of APIs and intermediates. The major members in the team have Ph.D. or MSEE degrees from prominent universities in China and overseas. Except for first-class production and advanced research facilities, Eliv also has rich experience at intermediates and APIs, analytical method development and impurity research, new drug certificate to declare. Eliv has a comprehensive management system and the production base in Nantong passed the c-GMP certification.
Eliv cooperate with domestic famous design institutes to promote the enterprises growing rapidly, boost the existing and developing ability at the market competition. Now, Eliv’s products have been used in cardiovascular and cerebrovascular, anti-cancer, anti-Virus, respiratory system and so on. Major customers include but not limited in Mexico,Spain, Taiwan and so on.
|
|
|
|
|
Other / similar products of Shanghai Eliv Pharmaceutical Co., Ltd. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|